Common Contracts
3 similar Licensing and Distribution Agreement contracts by Auriga Laboratories, Inc.
LICENSING AND DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • October 19th, 2007 • Auriga Laboratories, Inc. • Pharmaceutical preparations • New York
Agreement made this 6th day of June, 2007, between Laboratoires Carilène S.A.S a corporation existing under the laws of France, and having its principal place of business at 7, rue du Chant des Oiseaux, 78360 Montesson-France (hereinafter referred to as “Supplier”), and Auriga Laboratories, Inc., existing under the laws of the State of Delaware, U.S.A, having its principal place of business at 2029 Century Park East, Suite 1130, Los Angeles, CA 90067 U.S.A. (hereinafter referred to as “Buyer”).
LICENSING AND DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • October 18th, 2007 • Auriga Laboratories, Inc. • Pharmaceutical preparations • New York
Agreement made this 6th day of June, 2007, between Laboratoires Carilène S.A.S a corporation existing under the laws of France, and having its principal place of business at 7, rue du Chant des Oiseaux, 78360 Montesson-France (hereinafter referred to as “Supplier”), and Auriga Laboratories, Inc., existing under the laws of the State of Delaware, U.S.A, having its principal place of business at 2029 Century Park East, Suite 1130, Los Angeles, CA 90067 U.S.A. (hereinafter referred to as “Buyer”).
CONFIDENTIAL TREATMENT REQUESTED Confidential Portions of this Agreement Which Have Been Redacted Are Marked With Brackets “[***]”. The Omitted Material Has Been Filed Separately With The Securities and Exchange Commission. LICENSING AND DISTRIBUTION...Licensing and Distribution Agreement • August 9th, 2007 • Auriga Laboratories, Inc. • Pharmaceutical preparations • New York
Agreement made this 6th day of June, 2007, between Laboratoires Carilène S.A.S a corporation existing under the laws of France, and having its principal place of business at 7, rue du Chant des Oiseaux, 78360 Montesson-France (hereinafter referred to as “Supplier”), and Auriga Laboratories, Inc., existing under the laws of the State of Delaware, U.S.A, having its principal place of business at 2029 Century Park East, Suite 1130, Los Angeles, CA 90067 U.S.A. (hereinafter referred to as “Buyer”).
